Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Rabeprazole is a proton pump inhibitor (PPI) widely utilized in clinical medicine to suppress gastric acid secretion. Chemically known as sodium rabeprazole or rabeprazole sodium, its molecular formula is C17H19F2N3O4S, and it carries the unique CAS Registry Number 117976-40-8 for the free acid form. Structurally, this compound features a pyridine ring substituted with fluoromethyl groups and a sulfinyl moiety, which are critical for its pharmacological activity and stability within the acidic environment of the stomach.
The primary therapeutic application of Rabeprazole involves the treatment of gastroesophageal reflux disease (GERD), where it effectively alleviates symptoms such as heartburn and regurgitation by healing erosive esophagitis. It is also indicated for the short-term management of duodenal ulcers and benign gastric ulcers. Furthermore, clinicians prescribe it in combination with antibiotics to eradicate Helicobacter pylori infections, a major cause of peptic ulcer disease. Due to its rapid onset of action and high bioavailability, Rabeprazole offers a distinct advantage over some other PPIs, particularly in patients who may have variable metabolic responses to other agents in the same class.
Mechanistically, Rabeprazole acts by irreversibly inhibiting the H+/K+-ATPase enzyme system located at the secretory surface of gastric parietal cells. This "proton pump" is responsible for the final step of acid production; blocking it significantly reduces both basal and stimulated gastric acid secretion. Unlike some older PPIs, Rabeprazole demonstrates less dependence on cytochrome P450 enzymes for metabolism, potentially reducing drug-drug interactions. The standard dosage typically ranges from 20 mg to 40 mg once daily, administered orally before meals. While generally well-tolerated, long-term use requires monitoring for potential side effects such as magnesium deficiency, bone fractures, or vitamin B12 malabsorption. As a cornerstone therapy for acid-related disorders, Rabeprazole remains a vital tool in modern gastroenterology, providing effective relief and promoting mucosal healing for millions of patients worldwide.